HIF1A and breast cancer: Hypoxia-mediated induction of HIF-1α has been strongly linked to breast cancers developing therapy resistance, which may present an interesting opportunity to explore therapeutics to target the HIF axis in endocrine-resistant disease (Yong et al., 2022; Gray et al., 1953; Samanta et al., 2014).